Lean Meds vs Wholesome Clinic
The widest coverage here against the narrowest, and the cheapest opener against the clearest ladder.
Lean Meds
Editorial
$79/mo
Four terms published per molecule, with the month-to-month figure printed rather than implied. Compounded semaglutide stands at $79 a month; the advertised $69 is the twelve-month prepay tier. No membership is charged beside the medication, read in August 2026.
Pick it for: Buyers who want the lowest held figure and national shipping
Wholesome Clinic
Editorial
$109/mo
A self-pay practice that publishes the whole dose ladder rather than an opening figure. Semaglutide runs from $149 injected and $109 oral, tirzepatide from $349 injected and $249 oral, and each opens a three-rung ladder the pages print in full. Seeing the second and third rungs before enrolling is the disclosure; the tirzepatide injection ends $200 above where it starts. Coverage is seven states.
Pick it for: Buyers in Texas, Colorado, New Mexico, Oklahoma, Louisiana, Oregon or Arkansas
Our verdict
LeanMeds opens at $79 across fifty states with a flat rate; Wholesome Clinic opens at $109 in seven states and publishes every rung. Only one of them is available to most readers.
What actually separates them
Lean Meds and Wholesome Clinic state different things about published price and where you can use it. Everything else they publish, they publish the same way.
Wholesome Clinic costs $30 more than Lean Meds — 38% more for the same molecule. Whether that buys anything is what the rest of this page is for.
Over twelve months that is about $948 at Lean Meds against $1,308 at Wholesome Clinic — a difference of $360.
| Lean Meds | Wholesome Clinic | |
|---|---|---|
| Published price | $79/mo | $109/mo |
| Where you can use it | 50 states | 7 states |
Before you choose either
Ask both sellers what dose the monthly price buys before you compare the two figures. A price is only a price once you know what quantity it is attached to, and a seller that will not answer has told you something. Set both against every published price we hold rather than against each other alone.
Our take is computed from a published rubric that does not read commercial status, and what is known about safety applies to both of them equally.